Outcomes of Allogeneic Stem Cell Transplant (allo-SCT) Recipients in the Era of Newer Antifungal Agents

Authors

  • Nishi Shah Winship Cancer Institute, Emory University, Atlanta, GA, United States; Rollins School of Public Health, Emory university, Atlanta, GA, United States
  • Ajay K. Nooka Winship Cancer Institute, Emory University, Atlanta, GA, United States
  • Sagar Lonial
  • Hannah J. Khoury Winship Cancer Institute, Emory University, Atlanta, GA, United States
  • Edmund Waller Winship Cancer Institute, Emory University, Atlanta, GA, United States
  • Amelia Langston Winship Cancer Institute, Emory University, Atlanta, GA, United States

DOI:

https://doi.org/10.5210/ojphi.v6i1.5143

Abstract

Data from large patient samples evaluating the magnitude of benefit with the newer anti-fungal agents are lacking. We have analyzed the Nationwide Inpt Sample (NIS) database to evaluate the trends in the incidence of fungal infections and to evaluate the potential impact of newer anti-fungal agents on in-hospital mortality among allo-SCT recipients. Our data suggests that the use of newer anti-fungal agents has an impact on the survivability of fungal infections in the setting of allo-SCT.

Author Biography

Nishi Shah, Winship Cancer Institute, Emory University, Atlanta, GA, United States; Rollins School of Public Health, Emory university, Atlanta, GA, United States

I am a medical doctor from India, currently pursuing master's degree in epidemiology at Rollins School of Public Health.

Downloads

Published

2014-03-09

How to Cite

Shah, N., Nooka, A. K., Lonial, S., Khoury, H. J., Waller, E., & Langston, A. (2014). Outcomes of Allogeneic Stem Cell Transplant (allo-SCT) Recipients in the Era of Newer Antifungal Agents. Online Journal of Public Health Informatics, 6(1). https://doi.org/10.5210/ojphi.v6i1.5143

Issue

Section

Poster Presentations